TUSTIN, CA: Management to Review Recent Interim Phase II Data Demonstrating Statistically Significant Survival Improvement in Bavituximab-Treated Lung Cancer Patients
...
TUSTIN, CA: Interim Data Show Doubling of Median Overall Survival in Bavituximab-Treated Patients from Double-Blind, Placebo-Controlled Phase II Trial in Second-Line Non-Small Cell Lung Cancer; Recent Data Strong ...
Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.